Merve Dede
Impact in
- Immunology top 10%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Oncology top 10%
- CAR-T cell therapy research
Papers in
- Oncology 6
- CAR-T cell therapy research 5
- Co-authors
- Traver Hart (6 shared papers)Eiru Kim (3 shared papers)Megan E. McLaughlin (2 shared papers)Ken Chen (6 shared papers)Vakul Mohanty (6 shared papers)Walter F. Lenoir (2 shared papers)Medina Colic (2 shared papers)May Daher (2 shared papers)
- Journals
- Cancer Cell (2 papers)Nucleic Acids Research (2 papers)Nature Communications (2 papers)Nature (2 papers)Gut (1 paper)
- Partner nations
- United StatesFranceGermany
In The Last Decade
Merve Dede
18 papers receiving 768 citations
Merve Dede's Hit Papers
Peers
Comparison fields: 5 of 63
- Immunology 295
- Oncology 307
- Molecular Biology 271
- Aging 6
- Cancer Research 41
Countries citing papers authored by Merve Dede
This map shows the geographic impact of Merve Dede's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Merve Dede with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Merve Dede more than expected).
Fields of papers citing papers by Merve Dede
This network shows the impact of papers produced by Merve Dede. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Merve Dede. The network helps show where Merve Dede may publish in the future.
Co-authors
The 25 scholars most cited alongside Merve Dede, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial Hit paper breakdown → | 2024 | 357 |
| 2 | 2020 | 75 | |
| 3 | 2023 | 68 | |
| 4 | 2019 | 64 | |
| 5 | 2024 | 54 | |
| 6 | 2025 | 29 | |
| 7 | 2022 | 28 | |
| 8 | 2025 | 22 | |
| 9 | 2024 | 21 | |
| 10 | 2021 | 18 | |
| 11 | 2024 | 12 | |
| 12 | 2022 | 10 | |
| 13 | 2016 | 8 | |
| 14 | 2024 | 8 | |
| 15 | 2023 | 4 | |
| 16 | 2026 | 2 | |
| 17 | 2026 | 1 | |
| 18 | 2026 | 1 | |
| 19 | 2024 | 1 | |
| 20 | 2024 | 0 |
About Merve Dede
Merve Dede is a scholar working on Oncology, Cancer Research, Immunology, Molecular Biology and Hematology, having authored 21 papers that have together received 783 indexed citations. Recurring topics across this work include CAR-T cell therapy research (5 papers), Immune Cell Function and Interaction (5 papers), CRISPR and Genetic Engineering (4 papers), Single-cell and spatial transcriptomics (4 papers), Gene Regulatory Network Analysis (2 papers), Protein Degradation and Inhibitors (2 papers), Acute Myeloid Leukemia Research (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Immunology (295 citations), Oncology (307 citations), Molecular Biology (271 citations), Aging (6 citations) and Cancer Research (41 citations). Merve Dede has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Traver Hart, Eiru Kim, Megan E. McLaughlin, Ken Chen, Vakul Mohanty, Walter F. Lenoir, Medina Colic, May Daher, Gang Wang and Yuefan Huang. Their work appears in journals such as Cancer Cell, Nucleic Acids Research, Nature Communications, Nature and Gut.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.